Research Study

A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia
Principal Investigator 
Ging-Yuek Robin Hsiung

Overview

Body Locations and Systems 
Dementia
ClinicalTrials.gov# 
NCT03260920
Status 
Recruiting
Study Start/End 
May 11, 2018 to Dec 31, 2019
Locations 
UBC Hospital
Name/Title 
Eloise Nicklin, Clinical Trials Coordinator
Phone 
604-822-0324
Email Address 
eloise.nicklin@vch.ca
Purpose of Study 

The purpose of this study is to assess the safety, tolerability and effects on behaviour of Syntocinon given intranasally (by a spray into the nostrils) compared to placebo (an inactive saline substance that contains no medication) in participants with frontotemporal dementia/Pick's disease.

recruitment poster

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.